2 drug(s) with this reaction
11 total reports
Disease Recurrence has been reported as an adverse reaction across 2 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 11 adverse event reports mention disease recurrence in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with disease recurrence, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have disease recurrence listed in their FDA adverse event reports, sorted by report count:
In addition to disease recurrence, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
2 drug(s) manufactured by Haleon Us Holdings Llc have disease recurrence listed in their FDA adverse event reports: IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR.
There are a combined 11 reports of disease recurrence across 2 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.